default author photo

Lujun Shen

Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy

Guangzhou, 510060

China

SCHOLARLY PAPERS

3

DOWNLOADS

177

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Outlier Contrast Response to Anti-PD1 Treatment in Liver Metastasis of Uveal Melanoma Reveals Inducible Regulatory T Cell in Directing Anti-Tumor Immune Response

Number of pages: 28 Posted: 01 Oct 2020
Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University (SYSU) - Department of Pathology, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy
Downloads 84 (777,583)

Abstract:

Loading...

Uveal Melanoma, iTreg, pembrolizumab, Differential Response, PRDM1

2.

Anti-Tumor Immune Response by Combining Cryoablation and Transarterial Infusion of Pembrolizumab (CATAP) for Liver Metastases of Melanoma

Number of pages: 34 Posted: 24 Sep 2019
Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Seventh Affiliated Hospital, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Intelligence Technology Co. Ltd, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy
Downloads 52 (1,041,696)

Abstract:

Loading...

Melanoma; Liver metastasis; Cryoablation; Pembrolizumab; Efficacy

3.

Hepatic Resection Versus Transarterial Chemoembolization for the Intermediate Stage Hepatocellular Carcinoma: A Cohort Study

Number of pages: 19 Posted: 29 Oct 2020
Fujian Medical University - Department of Oncology, Fujian Medical University - Fujian Center for Safety Evaluation of New Drug, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Fujian Medical University - Department of Hepatobiliary Disease and Fujian Medical University - Department of Oncology
Downloads 41 (1,170,409)

Abstract:

Loading...

hepatic resection, intermediate-stage hepatocellular carcinoma, transarterial chemoembolization, overall mortality,real-world study